Tryptophan Update: Helpful Adjunct and Innocent Bystander

References

• Update—eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan—United States, through August 24, 1990. MMWR 1990; 39: 587–9; 789–90
   PubMedGoogle Scholar
• The Pharmacological Basis of Therapeutics, 9th edn., A Gilman, A G Gilman, L S Goodman. MacMillan, New York 1990
   Google Scholar
• South J A. Safety of amino acids as dietary supplements. Rockville, MD 1993, Comment upon the LSRO/FASEB Report of the same name
   Google Scholar
• Belongia E A, Hedberg C W, Gleich G J, et al. An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N Engl J Med 1990; 323: 357–65
   PubMed Web of Science ®Google Scholar
• Slutsker L, et al. Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturer. JAMA 1990; 264: 213–17
   PubMed Web of Science ®Google Scholar
• Tyson D, personal communication, 20 July 1993
   Google Scholar
• Sternberg E, et al. Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa. N Engl J Med 1980; 303: 782–7
   PubMed Web of Science ®Google Scholar
• Cole J O, Teicher M H, Glod C. Emergence of intense suicidal preoccupation during fluoxetine (Prozac) treatment. Am J Psych 1990; 147: 207–10
   PubMed Web of Science ®Google Scholar
• Altschul R, Hoffer A, Stephen J D. Influence of nicotinic acid on serum cholesterol in man. Arch Biochem 1955; 54: 558–9
   PubMed Web of Science ®Google Scholar
• Gilman A G, Goodman L S, Rall T W, Murad F. Pharmacological Basis of Therapeutics, 7th edn. MacMillan, NY 1985; 834–6
   Google Scholar
• Thomson J, Rankin H, Ashcroft G W, et al. The treatment of depression in general practice; a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo. Psychol Med 1982; 12: 741
   PubMed Web of Science ®Google Scholar
• Jaffe R, De Renzo E. Immune competence in the long lived. Clinical Chemistry Guidebook, R Jaffe, P Yannick. HSC Pub, Reston, VA 1990; 188–204
   Google Scholar
• Griffiths R S, De Jong D C, Nelson J D. Relation of arginine-lysine antagonism to herpes simplex growth in tissue culture. Chemotherapy 1981; 27: 209
   PubMed Web of Science ®Google Scholar
• Griffiths R S, De Jong D C, Kagan C. A multi-centered study of lysine therapy in herpes simplex infection. Dermatologica 1978; 156: 257
   PubMedGoogle Scholar
• Davies S, Stewart A. Nutritional Medicine. Avon Pub, NY 1987
   Google Scholar
• Hinds A. Nutrition as modulators of immune function. Can Med Assoc J 1991; 145: 35
   Google Scholar
• Fauci A S, Harley J B, Roberts W C, Ferrans V J, Gralnick H R, Bjornson B H. NIH Conference. The idiopathic hypereosinophilic syndrome. Clinical, pathologic, and therapeutic considerations. Ann Int Med 1982; 97: 78–92
   PubMed Web of Science ®Google Scholar
• Claue D J, et al. Eosinophilia-myalgia syndrome not associated with dietary supplement ingestion. Rheumatology Meeting, Abstract. 1993
   Google Scholar
• Jaffe R. Eosinophilia-myalgia syndrome caused by contaminated tryptophan. Intl J Biosocial Med Res 1989; 11: 181–4
   Google Scholar
• Caston J C, Rofs J B, Fogarty C M, Applebaum M L, Smith W P, Jr, Littlefield R H. Treatment of refractory eosinophilia myalgia syndrome associated with ingestion of L-tryptophan containing products. Adv Therapies 1990; 7: 1–23
   PubMedGoogle Scholar
• Mayeno A N, et al. Characterization of ‘peak E’, a novel amino acid associated with eosinophilia myalgia syndrome. Science 1990; 250: 1707–8
   PubMed Web of Science ®Google Scholar
• Sakimoto K. The cause of eosinophilia-myalgia syndrome associated with tryptophan use. N Engl J Med 1990; 323: 992–3
   PubMed Web of Science ®Google Scholar
• Crofford L J, Rader J I, Dalakas M C, et al. L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat. J Clin Invest 1990; 86: 1757–63
   PubMed Web of Science ®Google Scholar
• Belongia E A, Hedberg C W, Gleich G J, et al. An investigation of the cause of eosinophilia-myalgia syndrome associated with tryptophan use. N Engl J Med 1990; 264: 213–17
   Google Scholar
• Moroni F, . Tryptophan metabolites and excitatory amino acid receptors: studies in physiology and pathology. Neurotoxicity of Excitatory Amino Acids, A Guidotti, et al. Raven Press, NY 1990; 203–16
   Google Scholar
• South J A. Safety of amino acids as dietary supplements. Rockville, MD 1993, Comment on the LSRO/FASEB Report of the same name
   Google Scholar
• Harper A E. Protein quality, amino acid balance, utilization, and evaluation of diets containing amino acids as therapeutic agents. Nutr 1993; 9: 460–9
   PubMed Web of Science ®Google Scholar
• Harper A E. Effects of ingesting disproportionate amounts of amino acids. Physiol Rev 1970; 50: 428–558
   PubMed Web of Science ®Google Scholar
• Kilbourne E M, Berneri J, Jr, Posada-de la Paz M, et al. Chemical correlates of pathogenicity of oils related to the toxic oil syndrome epidemic in Spain. N Engl J Med 1988; 127: 1210–27
   Google Scholar